{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T21:07:30Z","timestamp":1762808850400},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T00:00:00Z","timestamp":1572393600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T00:00:00Z","timestamp":1572393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Occurrence of cardiovascular disease (CVD) in the setting of chronic kidney disease (CKD) can be described as a \u201ccruel alliance\u201d, with CVD responsible for about half of all deaths among CKD patients. Chronic kidney disease patients are more likely to die from CVD than progress to end stage kidney disease (ESKD). Dyslipidaemia, a known traditional risk factor for CVD, is highly prevalent among CKD patients and with an even higher frequency among ESKD patients on dialytic therapies. Prolonged exposure of continuous ambulatory peritoneal dialysis (CAPD) patients to high glucose concentrations in CAPD fluid have been associated with increased risk of cardiovascular events. In this study, we investigated the relationship of atherosclerotic vascular disease (AsVD) to clinical and echocardiographic parameters among black South Africans with CKD (stage 3) and ESKD on CAPD and haemodialysis (HD).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This was a cross-sectional study of 40 adult (18\u201365\u2009years) non-diabetic CKD patients (kidney disease outcome quality initiative [KDOQI] stage 3), 40 ESKD patients on CAPD, 40 ESKD patients on HD and 41 age and sex-matched healthy controls. An interviewer-administered questionnaire was used to obtain information on participants\u2019 sociodemographic and cardiovascular risk factors. Anthropometric parameters were measured. Serum blood samples were analysed for creatinine, albumin and lipid profile; lipoprotein ratios, Framingham\u2019s risk score and the 10-year risk of developing coronary heart disease (CHD) were calculated. Echocardiography was performed on all patients and carotid intima media thickness (CIMT) was measured in both right and left carotid arteries at 1\u2009cm proximal to the carotid bulb. Spearman\u2019s rank correlation and binary logistic regression were conducted to determine the relationship of AsVD to clinical and echocardiographic parameters.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Atherosclerotic vascular disease was most prevalent among ESKD patients on CAPD (70%,<jats:italic>n<\/jats:italic>\u2009=\u200928\/40). Chronic kidney disease and HD patients exhibited a similar prevalence (47.5%,<jats:italic>n<\/jats:italic>\u2009=\u200919\/40), while the prevalence in controls was 17.1% (<jats:italic>n<\/jats:italic>\u2009=\u20097\/41). Presence of AsVD was associated with significantly older age, higher waist hip ratio (WHR), left ventricular mass index (LVMI) and Framingham\u2019s 10-year risk of developing CHD. Significant differences in clinical and echocardiographic parameters were observed when the study groups were compared. Age and LVH independently predicted AsVD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Atherosclerotic vascular disease was more prevalent among CAPD patients compared to pre-dialysis CKD and HD patients. Among all lipoprotein ratios assessed, non-HDL-C showed the most consistent significant difference between the groups. Age (&gt;\u200940\u2009years) and presence of LVH were independent predictors of AsVD.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12882-019-1583-8","type":"journal-article","created":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T20:44:43Z","timestamp":1572468283000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Atherosclerotic vascular disease is more prevalent among black ESKD patients on long-term\u00a0CAPD in South Africa"],"prefix":"10.1186","volume":"20","author":[{"given":"S. O.","family":"Oguntola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. O.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Vachiat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Manga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Naicker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,30]]},"reference":[{"key":"1583_CR1","unstructured":"National Kidney Foundation. K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kid. Dis. 2002; 39(suppl 1): S1-S266."},{"key":"1583_CR2","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1046\/j.1523-1755.64.s87.5.x","volume":"87","author":"AJ Collins","year":"2003","unstructured":"Collins AJ, Li S, Gilbertson DT, Liu J, Chen SC, Herzog CA. Chronic kidney disease and cardiovascular disease in the medicare population. Kidney Int Suppl. 2003;87:S24\u201331.","journal-title":"Kidney Int Suppl"},{"key":"1583_CR3","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1056\/NEJM197403282901301","volume":"290","author":"A Lindner","year":"1974","unstructured":"Lindner A, Charra B, Sherrard DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. New Eng J Med. 1974;290:697\u2013701.","journal-title":"New Eng J Med"},{"issue":"9","key":"1583_CR4","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/archinte.164.9.969","volume":"164","author":"M Rahman","year":"2004","unstructured":"Rahman M, Brown CD, Coresh J, Davis BR, Eckfeldt J, Kopyt N, et al. The prevalence of reduced glomerular filtration rate in older hypertensive patients and its association with cardiovascular disease: a report from the anti-hypertensive and lipid-lowering treatment to prevent heart attack trial. Arch Intern Med. 2004;164(9):969\u201376.","journal-title":"Arch Intern Med"},{"key":"1583_CR5","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.2215\/CJN.00070109","volume":"4","author":"JP Lash","year":"2009","unstructured":"Lash JP, Go AS, Appel LJ, He J, Ojo A, Rahman M, et al. Chronic renal insufficiency cohort (CRIC) study: baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol. 2009;4:1302\u201311.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1583_CR6","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.006259","volume":"6","author":"K Matsushita","year":"2017","unstructured":"Matsushita K, Kwak L, Sang Y, Ballew SH, Skali H, Shah AM, et al. Kidney disease measures and left ventricular structure and function: the atherosclerosis risk in communities\u2019 study. J Am Heart Assoc. 2017;6:e006259. https:\/\/doi.org\/10.1161\/JAHA.117.006259 .","journal-title":"J Am Heart Assoc"},{"key":"1583_CR7","doi-asserted-by":"publisher","unstructured":"Kaze FF, Kengne A, Djalloh AA, Ashuntantang G, Halle MP, Menanga AP, et al. Pattern and correlates of cardiac lesions in a group of sub-Saharan African patients on maintenance haemodialysis. Pan African Medical Journal. 2014; 17: 03 doi: https:\/\/doi.org\/10.11604\/pamj.2014.17.3.3422","DOI":"10.11604\/pamj.2014.17.3.3422"},{"issue":"1","key":"1583_CR8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1542-4758.2011.00622.x","volume":"16","author":"OC Amira","year":"2012","unstructured":"Amira OC, Naicker S, Manga P, Sliwa K, Mia A, Raal F, et al. Adiponectin and atherosclerosis risk factors in African haemodialysis patients: a population at low risk for atherosclerotic cardiovascular disease. Hemodialysis Int. 2012;16(1):59\u201368.","journal-title":"Hemodialysis Int"},{"key":"1583_CR9","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/j.1440-1797.2012.01612.x","volume":"17","author":"R Freercks","year":"2012","unstructured":"Freercks R, Swanepoel C, Carrara H, Moosa S, Lachman A, Rayner B. Vascular calcification in south African dialysis patients: ethnic variation, prevalence, detection and haemodynamic correlates. Nephrology. 2012;17:607\u201315.","journal-title":"Nephrology"},{"key":"1583_CR10","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1093\/ndt\/gfg027","volume":"18","author":"CC Szeto","year":"2003","unstructured":"Szeto CC, Wong TY, Chow KM, Leung CB, Li PK. Are peritoneal dialysis patients with and without residual renal function equivalent for survival? Insight from a retrospective review of the cause of death. Nephrol Dial Transplant. 2003;18:977\u201382.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"1583_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0156642","volume":"11","author":"RA Tamayo-Isla","year":"2016","unstructured":"Tamayo-Isla RA, Ameh O, Mapiye D, Swanepoel CR, Bello AK, Ratsela AR, et al. Baseline predictors of mortality among predominantly rural dwelling end-stage renal disease patients on chronic dialysis therapies in Limpopo. South Africa PLoS ONE. 2016;11(6):e0156642. https:\/\/doi.org\/10.1371\/journal.pone.0156642 .","journal-title":"South Africa PLoS ONE"},{"key":"1583_CR12","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/978-3-319-09665-0_13","volume":"224","author":"M Schuchardt","year":"2015","unstructured":"Schuchardt M, Tolle M, Van der Giet M. High density lipoprotein structural and functional changes under uraemic conditions and the therapeutic consequences. Handb Exp Pharmacol. 2015;224:423\u201353.","journal-title":"Handb Exp Pharmacol"},{"issue":"8","key":"1583_CR13","first-page":"708","volume":"97","author":"R Norman","year":"2007","unstructured":"Norman R, Bradshaw D, Steyn K, Gaziano T. The south African comparative risk assessment collaborating group. Estimating the burden of disease attributable to high cholesterol in South Africa in 2000. S Afr Med J. 2007;97(8):708\u201315.","journal-title":"S Afr Med J"},{"key":"1583_CR14","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/089686080602600503","volume":"26","author":"S Shurraw","year":"2006","unstructured":"Shurraw S, Tonelli M. Statin for treatment of dyslipidaemia in chronic kidney disease. Perit Dial Int. 2006;26:523\u201339.","journal-title":"Perit Dial Int"},{"key":"1583_CR15","doi-asserted-by":"crossref","first-page":"L220","DOI":"10.1177\/089686080202200209","volume":"22","author":"JB Moberly","year":"2002","unstructured":"Moberly JB, Attman PO, Samuelsson O, Johansson AC, Knight-Gibson AP. Alteration in lipoprotein composition in peritoneal dialysis patients. Perit Dial Int. 2002;22:L220\u20138.","journal-title":"Perit Dial Int"},{"issue":"17","key":"1583_CR16","first-page":"1098","volume":"317","author":"RD Mosteller","year":"1987","unstructured":"Mosteller RD. Simplified calculation of body surface area. N Engl J Med. 1987;317(17):1098.","journal-title":"N Engl J Med"},{"issue":"37","key":"1583_CR17","doi-asserted-by":"publisher","first-page":"e8058","DOI":"10.1097\/MD.0000000000008058","volume":"96","author":"Gaojun Cai","year":"2017","unstructured":"Cai G, Ganwei S, Sheliang X, Wei L. The atherogenic index is a strong and independent predictor for coronary artery disease in the Chinese Han population. Medicine 2017; 96: 37(e8058).","journal-title":"Medicine"},{"key":"1583_CR18","doi-asserted-by":"publisher","first-page":"785","DOI":"10.7326\/0003-4819-156-11-201203200-00391","volume":"156","author":"A Early","year":"2012","unstructured":"Early A, Miskulin D, Lamb EJ, Levey AS, Uhliq K. Estimating equations for glomerular filtration rate in the era of creatinine standardization. A systematic review. Ann Intern Med. 2012;156:785\u201395.","journal-title":"Ann Intern Med"},{"key":"1583_CR19","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"RM Lang","year":"2005","unstructured":"Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for cardiac quantification. A report from the American Society of Echocardiography\u2019s guidelines and standard committee and the chamber quantification writing group, developed in conjunction with the European association of echocardiography, a branch of the European association of cardiology. J Am Soc Echocardiogr. 2005;18:1440\u201363.","journal-title":"J Am Soc Echocardiogr"},{"key":"1583_CR20","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1161\/01.CIR.96.5.1432","volume":"96","author":"ML Bots","year":"1997","unstructured":"Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction. Circulation. 1997;96:1432\u20137.","journal-title":"Circulation."},{"key":"1583_CR21","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1159\/000342794","volume":"36","author":"GA Adeseun","year":"2012","unstructured":"Adeseun GA, Xie D, Wang X, Joffe MM, Mohler ER, Townsend RR, et al. Carotid plaque, carotid intima-media thickness and coronary calcification equally discriminate prevalent cardiovascular disease in kidney disease. Am J Nephrol. 2012;36:342\u20137.","journal-title":"Am J Nephrol"},{"key":"1583_CR22","first-page":"285","volume":"97","author":"AK Paul","year":"2007","unstructured":"Paul AK, Mash B, Rupesinghe G. Peripheral arterial disease \u2013 high prevalence in rural black south Africans. S Afri Med J. 2007;97:285\u20138.","journal-title":"S Afri Med J"},{"issue":"5","key":"1583_CR23","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1093\/ndt\/gfp652","volume":"25","author":"P Kalk","year":"2010","unstructured":"Kalk P, Ruckert M, Godes M, et al. Does endothelin B receptor deficiency ameliorate the induction of peritoneal fibrosis in experimental peritoneal dialysis? Nephrol Dial Transplant. 2010;25(5):1474\u20138.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"1583_CR24","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1177\/089686080702702s15","volume":"27","author":"K Kaneko","year":"2007","unstructured":"Kaneko K, Hamada C, Tomino Y. Peritoneal fibrosis intervention. Perit Dial Int. 2007;27(2):S82\u20136.","journal-title":"Perit Dial Int"},{"key":"1583_CR25","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1172\/JCI111776","volume":"75","author":"M Modan","year":"1985","unstructured":"Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, et al. Hyperinsulinaemia: a link between hypertension obesity and glucose intolerance. J Clin Invest. 1985;75:809\u201317.","journal-title":"J Clin Invest"},{"issue":"2","key":"1583_CR26","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/0026-0495(95)90270-8","volume":"44","author":"F Assimacopoulos-Jeannet","year":"1995","unstructured":"Assimacopoulos-Jeannet F, Brichard S, Rencurel F, Cusin I, Jeanrenaud B. In-vivo effects of hyperinsulinaemia on lipogenic enzymes and glucose transporter expression in rat liver and adipose tissue. Metabolism. 1995;44(2):228\u201333.","journal-title":"Metabolism"},{"issue":"3","key":"1583_CR27","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1053\/j.ajkd.2005.05.016","volume":"46","author":"B Bammens","year":"2005","unstructured":"Bammens B, Evenepoel P, Verbeke K, Vanrenterghem Y. Time profiles of peritoneal and renal clearances of different uraemic solutes in incident peritoneal dialysis patients. Am J Kid Dis. 2005;46(3):512\u20139.","journal-title":"Am J Kid Dis"},{"issue":"1","key":"1583_CR28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/ndt\/gfm475","volume":"23","author":"S Schmidt","year":"2008","unstructured":"Schmidt S, Westhoff TH, Krauser P, Zidek W, Van der Giet M. The uraemic toxin phenylacetic acid increases the formation of reactive oxygen species in vascular smooth muscle cells. Nephrology Dialysis Transplantation. 2008;23(1):65\u201371.","journal-title":"Nephrology Dialysis Transplantation"},{"key":"1583_CR29","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.numecd.2014.04.006","volume":"24","author":"M Rossi","year":"2014","unstructured":"Rossi M, Campbell K, Johnson D, Stanton T, Pascoe E, Hawley C, et al. Uraemic toxins and cardiovascular disease across the chronic kidney spectrum: an observational. Study. Nutrition. Metabolism and cardiovascular diseases. 2014;24:1035\u201342.","journal-title":"Metabolism and cardiovascular diseases"},{"issue":"17","key":"1583_CR30","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1001\/archinte.166.17.1884","volume":"166","author":"NI Parikh","year":"2006","unstructured":"Parikh NI, Hwang S, Larson MG. Cardiovascular disease risk factors in chronic kidney disease. Overall burden and rates of treatment and control. Arch Intern Med. 2006;166(17):1884\u201391.","journal-title":"Arch Intern Med"},{"issue":"5","key":"1583_CR31","first-page":"473","volume":"102","author":"JE Burmeister","year":"2014","unstructured":"Burmeister JE, Mosmann CB, Costa VB, Saraiva RT, Grandi RR, Bastos JP. Prevalence of cardiovascular risk factors in haemodialysis patients- the CORDIAL study. Arq Bras Cardiol. 2014;102(5):473\u201380.","journal-title":"Arq Bras Cardiol"},{"key":"1583_CR32","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1161\/01.STR.0000147719.27237.14","volume":"35","author":"JH Stein","year":"2004","unstructured":"Stein JH, Dougas PS, Srinivasan SR, Bond MG, Tang R, Li S, et al. Distribution and cross-sectional age-related increases of carotid artery intima-media thickness in young adults. Stroke. 2004;35:2782\u20137.","journal-title":"Stroke"},{"issue":"4","key":"1583_CR33","doi-asserted-by":"publisher","first-page":"192","DOI":"10.4103\/aam.aam_9_17","volume":"16","author":"H Khutan","year":"2017","unstructured":"Khutan H, Aggarwal S, Kajal KS, Garg R, Kaur R, Kaur A. Study of carotid intima media thickness in essential hypertension with or without left ventricular hypertrophy. Ann Afr Med. 2017;16(4):192\u20135.","journal-title":"Ann Afr Med"},{"key":"1583_CR34","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1042\/cs0930519","volume":"93","author":"D Lyons","year":"1997","unstructured":"Lyons D, Roy S, Patel M, Benjamin N, Swift CG. Impaired nitric oxide-mediated vasodilatation and total body nitric oxide production in healthy old age. Clin Sci. 1997;93:519\u201325.","journal-title":"Clin Sci"},{"issue":"4","key":"1583_CR35","first-page":"818","volume":"28","author":"B Tirmenstajn-Jankovic","year":"2017","unstructured":"Tirmenstajn-Jankovic B, Dimkovic N, Radojicic Z, Bastac D, Zivanovic M, Zikic S. Association between age and cardiovascular status by Echosonography in asymptomatic predialysis patients with chronic kidney disease. Saudi J Kidney Dis Transplant. 2017;28(4):818\u201329.","journal-title":"Saudi J Kidney Dis Transplant"},{"issue":"Supplement 4","key":"1583_CR36","doi-asserted-by":"publisher","first-page":"192","DOI":"10.2165\/00003495-198600314-00023","volume":"31","author":"Franz H. Messerli","year":"1986","unstructured":"Messerli FH, Schmieder R. Left ventricular hypertrophy. A cardiovascular risk factor in essential hypertension. Drugs. 1986; 31 Suppl 4: 192\u2013201.","journal-title":"Drugs"},{"issue":"6","key":"1583_CR37","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1097\/MNH.0000000000000067","volume":"23","author":"D Charytan","year":"2014","unstructured":"Charytan D. Is left ventricular hypertrophy a modifiable risk factor in end-stage renal disease. Curr Opin Nephrol Hypertens. 2014;23(6):578\u201385.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"1583_CR38","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","volume":"322","author":"D Levy","year":"1990","unstructured":"Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med. 1990;322:1561\u20136.","journal-title":"N Engl J Med"},{"key":"1583_CR39","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jacc.2007.03.037","volume":"50","author":"DE Weiner","year":"2007","unstructured":"Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS, et al. The Framingham predictive instrument in chronic kidney disease. J Am Coll Cardiol. 2007;50:217\u201324.","journal-title":"J Am Coll Cardiol"},{"key":"1583_CR40","doi-asserted-by":"publisher","first-page":"91G","DOI":"10.1016\/0002-9149(87)90165-2","volume":"59","author":"PW Wilson","year":"1987","unstructured":"Wilson PW, Castelli WP, Kanel WB. Coronary risk prediction in adults (the Framingham heart study). Am J Cardiol. 1987;59:91G\u20134G.","journal-title":"Am J Cardiol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1583-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-019-1583-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1583-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T23:55:58Z","timestamp":1721951758000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-019-1583-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,30]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1583"],"URL":"https:\/\/doi.org\/10.1186\/s12882-019-1583-8","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,30]]},"assertion":[{"value":"13 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the authors gave their consent for the publication of this article.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There is no financial or non-financial competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"399"}}